Compare HRTX & NSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HRTX | NSAI |
|---|---|---|
| Founded | 1983 | 2026 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.1M | 47.9M |
| IPO Year | 2007 | 2026 |
| Metric | HRTX | NSAI |
|---|---|---|
| Price | $0.33 | $10.00 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.5M | 43.1K |
| Earning Date | 11-09-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $154,904,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $0.26 | $9.82 |
| 52 Week High | $1.58 | $10.00 |
| Indicator | HRTX | NSAI |
|---|---|---|
| Relative Strength Index (RSI) | 50.81 | 70.27 |
| Support Level | $0.28 | $9.82 |
| Resistance Level | $0.34 | N/A |
| Average True Range (ATR) | 0.03 | 0.02 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 42.72 | 100.00 |
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
NorthStrive Acquisition Corp I is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.